FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023853820> ?p ?o ?g. }

• W2023853820 endingPage "95" @default.
• W2023853820 startingPage "90" @default.
• W2023853820 abstract "To identify key prognostic clinical and imaging variables in patients undergoing yttrium-90 radioembolization ((90)Y) for liver malignancies.Patients with liver malignancies that progressed despite standard-of-care therapy were treated with (90)Y from 2002 to 2006. Baseline functional status, laboratory values, and diagnostic imaging were assessed before therapy. Imaging follow-up was performed 1 month after treatment and subsequently at 3-month intervals. Patients were followed for survival from the time of their first (90)Y treatment.Patients with follow-up imaging after radioembolization (N = 130) were included in this analysis. Primary malignancies included colon, neuroendocrine, and others. The following clinical variables had a significant effect on survival on multivariate analysis: Eastern Cooperative Oncology Group (ECOG) performance status (PS) greater than 0 (hazard ratio [HR], 7.98; 95% CI, 3.98-16), hepatic tumor burden of 51%-75% (HR, 2.46; 95% CI, 1.01-6.02), bilirubin level greater than 1.3 mg/dL (HR, 2.60; 95% CI, 1.27-5.34), hepatic metastases from breast cancer (HR, 2.51; 95% CI, 1.13-5.61), response on imaging based on World Health Organization (WHO) criteria (HR, 0.48; 95% CI, 0.24-0.94), and lymphocyte depression (HR, 0.56; 95% CI, 0.31-0.96). Among patients with colorectal cancer metastases to the liver, the HR for survival on univariate analysis for responders compared with nonresponders (per WHO criteria) was 0.26 (95% CI, 0.10-0.69).Cancer-related symptoms (ie, ECOG PS > 0), hepatic tumor burden greater than 50%, increased bilirubin levels, and hepatic metastases from breast cancer were found to be negative prognostic factors. Tumor response to therapy and lymphocyte depression were associated with favorable prognosis. Additionally, WHO response was identified to be a favorable prognostic factor in patients with colorectal cancer metastases. These findings may be useful when counseling patients regarding prognosis of their hepatic disease." @default.
• W2023853820 created "2016-06-24" @default.
• W2023853820 creator A5029706633 @default.
• W2023853820 creator A5030666817 @default.
• W2023853820 creator A5033464248 @default.
• W2023853820 creator A5034975837 @default.
• W2023853820 creator A5036972230 @default.
• W2023853820 creator A5045783160 @default.
• W2023853820 creator A5048419109 @default.
• W2023853820 creator A5059237604 @default.
• W2023853820 creator A5069675813 @default.
• W2023853820 creator A5070826744 @default.
• W2023853820 creator A5075153200 @default.
• W2023853820 creator A5087536545 @default.
• W2023853820 date "2010-01-01" @default.
• W2023853820 modified "2023-10-06" @default.
• W2023853820 title "Yttrium-90 Radioembolization for Liver Malignancies: Prognostic Factors Associated with Survival" @default.
• W2023853820 cites W1495055668 @default.
• W2023853820 cites W1570173114 @default.
• W2023853820 cites W1974613296 @default.
• W2023853820 cites W1976158860 @default.
• W2023853820 cites W1982345319 @default.
• W2023853820 cites W1991191090 @default.
• W2023853820 cites W1999949032 @default.
• W2023853820 cites W2010047598 @default.
• W2023853820 cites W2010397777 @default.
• W2023853820 cites W2033444814 @default.
• W2023853820 cites W2037435427 @default.
• W2023853820 cites W2054265070 @default.
• W2023853820 cites W2059334131 @default.
• W2023853820 cites W2072788416 @default.
• W2023853820 cites W2073016557 @default.
• W2023853820 cites W2076668534 @default.
• W2023853820 cites W2077014377 @default.
• W2023853820 cites W2086409122 @default.
• W2023853820 cites W2086622904 @default.
• W2023853820 cites W2139248078 @default.
• W2023853820 cites W2149469912 @default.
• W2023853820 cites W2153307137 @default.
• W2023853820 cites W2156946556 @default.
• W2023853820 cites W2169874604 @default.
• W2023853820 doi "https://doi.org/10.1016/j.jvir.2009.09.011" @default.
• W2023853820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19939705" @default.
• W2023853820 hasPublicationYear "2010" @default.
• W2023853820 type Work @default.
• W2023853820 sameAs 2023853820 @default.
• W2023853820 citedByCount "39" @default.
• W2023853820 countsByYear W20238538202012 @default.
• W2023853820 countsByYear W20238538202013 @default.
• W2023853820 countsByYear W20238538202014 @default.
• W2023853820 countsByYear W20238538202015 @default.
• W2023853820 countsByYear W20238538202016 @default.
• W2023853820 countsByYear W20238538202017 @default.
• W2023853820 countsByYear W20238538202018 @default.
• W2023853820 countsByYear W20238538202019 @default.
• W2023853820 countsByYear W20238538202020 @default.
• W2023853820 countsByYear W20238538202021 @default.
• W2023853820 countsByYear W20238538202022 @default.
• W2023853820 countsByYear W20238538202023 @default.
• W2023853820 crossrefType "journal-article" @default.
• W2023853820 hasAuthorship W2023853820A5029706633 @default.
• W2023853820 hasAuthorship W2023853820A5030666817 @default.
• W2023853820 hasAuthorship W2023853820A5033464248 @default.
• W2023853820 hasAuthorship W2023853820A5034975837 @default.
• W2023853820 hasAuthorship W2023853820A5036972230 @default.
• W2023853820 hasAuthorship W2023853820A5045783160 @default.
• W2023853820 hasAuthorship W2023853820A5048419109 @default.
• W2023853820 hasAuthorship W2023853820A5059237604 @default.
• W2023853820 hasAuthorship W2023853820A5069675813 @default.
• W2023853820 hasAuthorship W2023853820A5070826744 @default.
• W2023853820 hasAuthorship W2023853820A5075153200 @default.
• W2023853820 hasAuthorship W2023853820A5087536545 @default.
• W2023853820 hasConcept C121608353 @default.
• W2023853820 hasConcept C126322002 @default.
• W2023853820 hasConcept C143998085 @default.
• W2023853820 hasConcept C144301174 @default.
• W2023853820 hasConcept C207103383 @default.
• W2023853820 hasConcept C2776231280 @default.
• W2023853820 hasConcept C38180746 @default.
• W2023853820 hasConcept C44249647 @default.
• W2023853820 hasConcept C526805850 @default.
• W2023853820 hasConcept C71924100 @default.
• W2023853820 hasConcept C90924648 @default.
• W2023853820 hasConceptScore W2023853820C121608353 @default.
• W2023853820 hasConceptScore W2023853820C126322002 @default.
• W2023853820 hasConceptScore W2023853820C143998085 @default.
• W2023853820 hasConceptScore W2023853820C144301174 @default.
• W2023853820 hasConceptScore W2023853820C207103383 @default.
• W2023853820 hasConceptScore W2023853820C2776231280 @default.
• W2023853820 hasConceptScore W2023853820C38180746 @default.
• W2023853820 hasConceptScore W2023853820C44249647 @default.
• W2023853820 hasConceptScore W2023853820C526805850 @default.
• W2023853820 hasConceptScore W2023853820C71924100 @default.
• W2023853820 hasConceptScore W2023853820C90924648 @default.
• W2023853820 hasIssue "1" @default.
• W2023853820 hasLocation W20238538201 @default.
• W2023853820 hasLocation W20238538202 @default.
• W2023853820 hasOpenAccess W2023853820 @default.

• next